Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer

D Forman1, H Møller

  • 1Cancer Epidemiology Unit, Imperial Cancer Research Fund, Radcliffe Infirmary, Oxford.

Cancer Surveys
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Testicular cancer incidence is rising in men aged 15-54 globally, affecting both teratomas and seminomas. However, mortality rates are declining due to improved treatments, highlighting better prognosis for this cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood cancer incidence in South Africa, 1987-2007.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2015
Same author

The impact of cigarette smoking on life expectancy between 1980 and 2010: a global perspective.

Tobacco control·2015
Same author

Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.

International journal of cancer·2015
Same author

Global patterns of cardia and non-cardia gastric cancer incidence in 2012.

Gut·2015
Same author

The influence of geographical access to health care and material deprivation on colorectal cancer survival: evidence from France and England.

Health & place·2014
Same author

The Jeweller's Thumb: An Occupational Neuroma A Case Report.

Orthopedics·2014
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Testicular cancer predominantly impacts young and middle-aged men.
  • Recent data indicate a global increase in testicular cancer incidence across various risk populations.

Purpose of the Study:

  • To analyze trends in testicular cancer incidence and mortality rates.
  • To investigate changes in specific histological types and age groups.
  • To assess the impact of treatment advancements on patient prognosis.

Main Methods:

  • Analysis of incidence and mortality data from 13 and 9 national populations, respectively.
  • Examination of data stratified by age bands (15-34 and 35-54 years).
  • Histological category analysis for teratomas and seminomas in specific regions.

Related Experiment Videos

Main Results:

  • Testicular cancer incidence rates have increased in men aged 15-54 years globally between 1970 and 1985.
  • Both teratomas and seminomas show increasing incidence.
  • Despite rising incidence, testicular cancer mortality rates are declining across examined populations.

Conclusions:

  • Improvements in chemotherapy and treatment have led to a better prognosis for testicular cancer.
  • The rise in incidence suggests potential environmental risk factors, but their nature remains unknown, hindering prevention strategies.
  • Early diagnosis and advanced treatment remain crucial for managing testicular cancer effectively.